Collecting health data from people with and without type 2 diabetes
Collects health data from people with and without type 2 diabetes.
Key facts
- Who runs it
- University of Washington
- Where
- Birmingham, San Diego, and Seattle, United StatesSee the 3 sites
- Trial code
- Registry title
- AI Ready and Exploratory Atlas for Diabetes Insights
- Status
- Enrolling by invitation
- People taking part
- 4,000 people, planned
- Started
- 19 Jul 2023
- Expected to end
- 1 Jan 2027
- Type of study
- Observational, 4 groups
- Record updated
- 6 April 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 40 to 85, with or without type 2 diabetes, who can give consent and read and speak English.
- Age
- 40 to 85 years
- Sex
- All sexes can join.
- Disease stage
- People with type 2 diabetes at different stages, and people without diabetes, can join.
Main reasons for not taking part
- Older than 85 years
- Pregnancy
- Gestational diabetes
- Type 1 diabetes
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Adults (≥ 40 years old)
- Patients with and without type 2 diabetes
- Able to provide consent
- Must be able to read and speak English
Who cannot take part
- Gestational diabetes
- Type 1 diabetes
- Adults older than 85 years of age
- Pregnancy
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 85 years old?
Where in United States
- University of Alabama BirminghamBirmingham, United StatesEnrolling by invitation
- UC San DiegoSan Diego, United StatesEnrolling by invitation
- University of WashingtonSeattle, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
The study will collect a cross-sectional dataset of 4000 people across the US from diverse racial/ethnic groups who are either 1) healthy, or 2) belong in one of the three stages of diabetes severity (pre-diabetes/diet controlled, oral medication and/or non-insulin-injectable medication controlled, or insulin dependent), forming a total of four groups of patients. Clinical data (social determinants of health surveys, continuous glucose monitoring data, biomarkers, genetic data, retinal imaging, cognitive testing, etc.) will be collected. The purpose of this project is data generation to allow future creation of artificial intelligence/machine learning (AI/ML) algorithms aimed at defining disease trajectories and underlying genetic links in different racial/ethnic cohorts. A smaller subgroup of participants will be invited to come for a follow-up visit in year 4 of the project (longitudinal arm of the study). Data will be placed in an open-source repository and samples will be sent to the study sample repository and used for future research.
The 4 groups in the trial
- Healthy
Participants who do not have Type 1 or Type 2 Diabetes
- Pre-diabetes/Diet Controlled
Participants with pre-Type 2 Diabetes and those with Type 2 Diabetes whose blood sugar is controlled by diet
- Oral Medication and/or Non-insulin-injectable Medication Controlled
Participants with Type 2 Diabetes whose blood sugar is controlled by oral or injectable medications other than insulin
- Insulin Dependent
Participants with Type 2 Diabetes whose blood sugar is controlled by insulin
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- AI Ready and Exploratory Atlas for Diabetes Insights
- Plain-language title
- Collecting health data from people with and without type 2 diabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06002048, who can take part
- Record updated
- 6 April 2025